Quantcast

No FCA Claim from ‘Off-Label’ Marketing (access required)

By Deborah Elkins
Published: January 17, 2013

Tags: , ,

A pharmaceutical company employee has not stated a claim under the False Claims Act with general allegations that the company’s marketing of its “off-label” prescriptions and unnecessarily high-dose prescriptions of the company’s Kapidex drug necessarily meant that false claims for reimbursement had been submitted to federally sponsored health care plans; the 4th Circuit affirms dismissal ...
© Copyright 2013 Virginia Lawyers Media. All Rights Reserved.

Comments

You must be logged in to post comments.

VLW Verdicts & Settlements

Refine your search for VLW Verdict & Settlement Reports or send us your case results for publication. Database search feature available to VLW subscribers only - login required.

Log in to search the V & S Database

Submit a Verdict & Settlement Report

GET THE VLW DAILY ALERT

The Daily Alert from Virginia Lawyers Weekly brings you the latest legal news every morning in your e-mail. You’ll get headline news, a link to the day’s Top Opinion and more!

Click here to sign up for the Alert

STAY CONNECTED WITH VLW

Stay up-to-date with the latest news and information from Virginia Lawyers Weekly by subscribing to our RSS feeds and visiting our social media pages.

Feeds/Web 2.0: